CRT 2026

Breakout Group Discussion | Innovation

Facilitator(s)

• EH

  Elise Higgins

  Disclosure information not submitted.
• 

  Srini Potluri, MD

  Chief of Cardiology
  Baylor Scott and White The Heart Hospital Plano
  Frisco, Texas, United States

  Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Terumo Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• 

  Toby Rogers, MD, PhD

  Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease
  Georgetown University and MedStar Washington Hospital Center
  Washington, District of Columbia, United States

  Disclosure(s): Abbott: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Transmural Systems: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing)
• 

  Behnam N. Tehrani, MD

  System Associate Director for Interventional Cardiology and Executive Director of Cardiac Cath Labs
  Inova Health System
  Fairfax, Virginia, United States

  Disclosure(s): Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); ReCor: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• JW

  Jason Weidman, MS, MBA

  SVP & President, Coronary & RDN
  Medtronic

  Disclosure(s): Medtronic: Employee (Ongoing)

Roundtable Participant(s)

• 

  Alba Abril Molina, MD

  Interventional Cardiologist
  Virgen del Rocío University Hospital , Andalucia, Spain

  Disclosure(s): No financial relationships to disclose
• 

  Nyal Borges, MD FSCAI

  Director of Interventional Cardiology - Greater Charlotte Interventional Director of Venous Thrombosis Center of Excellence
  Advocate Health , North Carolina, United States

  Disclosure(s): No financial relationships to disclose
• 

  Krzysztof Leszek Bryniarski, MD, PhD, FESC

  Associate Professor
  Interventional Cardiology Department, st. John Paul II Hospital, Krakow, Poland
  Krakow, Poland

  Disclosure(s): No financial relationships to disclose
• 

  Brian D. McCauley, MD, MPH, RCIS

  Director Cardiogenic Shock Team, Director of Structural Innovation, Assistant Professor of Medicine
  Tower Heath System, Reading Hospital, Drexel University College of Medicine
  Wyomissing, Pennsylvania, United States

  Disclosure(s): No financial relationships to disclose
• 

  Poornima Mohan, MD

  Post CCT in interventional Cardiology , Northwest London deanery( RBH, ICHT, NPH ). EAPCI Education &Training Grant tenure RUMC, NL.
  CRT
  London, England, United Kingdom

  Disclosure(s): No financial relationships to disclose
• 

  Denizhan Ozdemir, MD, PhD

  Assistant Professor
  University of Rochester Medical Center

  Disclosure(s): No financial relationships to disclose
• 

  Jai Parekh, MD

  Interventional and Structural Cardiologist
  Nebraska Methodist Hospital
  Omaha, Nebraska, United States

  Disclosure(s): No financial relationships to disclose
• 

  Faisal Rahman, BMBCh, FACC, FSCAI

  Assistant Professor
  Johns Hopkins University

  Disclosure(s): No financial relationships to disclose
• 

  Michael Siah, MD

  Assistant Professor of Surgery
  UT Southwestern Medical Center
  Dallas, Texas, United States

  Disclosure(s): Abbott, Bayer, BD, Boston Scientific, Cook, CSI, Inari, Medtronic, Philips, Shockwave and VentureMed.: Consulting Fees (e.g., advisory boards) (Ongoing); Bard Peripheral Vascular, Veryan, Biotronik, Cook Medical, Gore & Associates, Medtronic, Philips, Terumo, TriReme, Shockwave, Med Alliance, Intact Vascular, B. Braun; CSI, Boston Scientific, University of Jena, Pluristem, PQ Bypass, Surmodics, Reflow: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Konstantinos Voudris, MD, PhD

  Interventional Cardiologist
  Allina Health Minneapolis Heart Institute
  Minneapolis, Minnesota, United States

  Disclosure(s): 4C Medical Technologies, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edward Lifesciences: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)